Subtype
Urinary Tract Neoplasm
CI-CAN-00001627Explore in graph →
Non-malignant558 active trials14 approved drugs29 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001627Explore in graph →
Clinical trials
2,187 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01343121 | Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy(Gemtrans) | completed | N/A | 50 | The Christie NHS Foundation TrustOTHER | 1 | Aug 13, 2021 | clinicaltrials |
| NCT01631552 | Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer | completed | Phase 1 / Phase 2 | 515 | Gilead SciencesINDUSTRY | 1 | Aug 12, 2021 |
| NCT04358718 | Influence of Opioids on Circulating Tumor Cells in Radical Cystectomy | completed | N/A | 44 | RenJi HospitalOTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT03063125 | Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer | completed | — | 25 | University of Kansas Medical CenterOTHER | 1 | Aug 3, 2021 | clinicaltrials |
| NCT02252549 | An International Randomized Study to Compare SPIES Versus WLI | completed | N/A | 700 | Clinical Research Office of the Endourological SocietyOTHER | 0 | Jul 28, 2021 | clinicaltrials |
| NCT03327883 | Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer | completed | — | 15 | National Cancer Institute (NCI)NIH | 1 | Jul 9, 2021 | clinicaltrials |
| NCT04601766 | A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets | completed | Phase 1 | 12 | Asieris Pharmaceuticals (AUS) Pty Ltd.INDUSTRY | 1 | Jun 30, 2021 | clinicaltrials |
| NCT02340650 | High Resolution Imaging for Early and Better Detection of Bladder Cancer(HRME_Bladder) | completed | — | 37 | The University of Texas Health Science Center, HoustonOTHER | 1 | Jun 25, 2021 | clinicaltrials |
| NCT04933604 | LPN in Patients With High-complex Renal Tumors | completed | — | 78 | Samsun Liv HospitalOTHER | 1 | Jun 22, 2021 | clinicaltrials |
| NCT02852252 | Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry | completed | — | 291 | University of PennsylvaniaOTHER | 1 | Jun 18, 2021 | clinicaltrials |
| NCT02298998 | Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study | completed | — | 41 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 14, 2021 | clinicaltrials |
| NCT00118040 | Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Jun 10, 2021 | clinicaltrials |
| NCT02009332 | Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer | completed | Phase 1 / Phase 2 | 21 | Aadi Bioscience, Inc.INDUSTRY | 1 | Jun 8, 2021 | clinicaltrials |
| NCT04885309 | Efficacy and Safety of Obturator Nerve Block During Transurethral Resection on Non-muscle Invasive Intermediate and High Risk Lateral Wall Bladder Tumours | completed | N/A | 104 | Ankara Training and Research HospitalOTHER | 1 | May 13, 2021 | clinicaltrials |
| NCT01762527 | Adaptive Radiotherapy Using Plan Selection for Bladder Cancer(plan selection) | completed | N/A | 65 | University of AarhusOTHER | 1 | May 6, 2021 | clinicaltrials |
| NCT01827943 | Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer(VESTOR) | completed | Phase 2 | 54 | Institut BergoniéOTHER | 1 | May 6, 2021 | clinicaltrials |
| NCT02647112 | Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma | completed | N/A | 1,050 | Nucleix Ltd.INDUSTRY | 4 | May 4, 2021 | clinicaltrials |
| NCT02700464 | The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma | completed | N/A | 680 | Nucleix Ltd.INDUSTRY | 2 | May 4, 2021 | clinicaltrials |
| NCT04872036 | Prognostic Biomarkers in Patients With Urothelial Carcinoma | completed | — | 66 | Hellenic Cooperative Oncology GroupOTHER | 0 | May 4, 2021 | clinicaltrials |
| NCT03257293 | A Trial of a Modified Cystoscopy Method to Reduce Pain Perception | completed | N/A | 93 | Western University, CanadaOTHER | 1 | Apr 27, 2021 | clinicaltrials |
| NCT02365818 | Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure(BOND2) | completed | Phase 2 | 66 | CG Oncology, Inc.INDUSTRY | 1 | Apr 14, 2021 | clinicaltrials |
| NCT04838873 | Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center | completed | N/A | 60 | Cairo UniversityOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT02552121 | Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 33 | Seagen Inc.INDUSTRY | 5 | Apr 8, 2021 | clinicaltrials |
| NCT00461591 | Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) | completed | Phase 3 | 802 | Spectrum Pharmaceuticals, IncINDUSTRY | 1 | Mar 30, 2021 | clinicaltrials |
| NCT03063255 | Comparison of Obturator Nerve Blockade and Neuromuscular Blockade | completed | Phase 4 | 60 | University of FloridaOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT02753309 | A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer | completed | Early Phase 1 | 33 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Mar 19, 2021 | clinicaltrials |
| NCT02818725 | I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations(GETUG-AFU19) | completed | Phase 3 | 133 | UNICANCEROTHER | 1 | Mar 9, 2021 | clinicaltrials |
| NCT02880176 | Steps to Eliminate Postoperative Problems(STEPP) | completed | N/A | 34 | University of PennsylvaniaOTHER | 1 | Mar 9, 2021 | clinicaltrials |
| NCT02800473 | Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection(CyPaM2) | completed | N/A | 10 | Institut de Cancérologie de LorraineOTHER | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04334226 | The Impact of Preoperative Urostomy Education on Patients and Families(StomABC Impact) | completed | — | 16 | University of Kansas Medical CenterOTHER | 1 | Mar 4, 2021 | clinicaltrials |
| NCT04052113 | Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st Line Chemotherapy in These High or Low Population for Stage IV Urothelial Cancer(YODO) | completed | — | 152 | AstraZenecaINDUSTRY | 1 | Mar 1, 2021 | clinicaltrials |
| NCT04768894 | Impact of Time to Re-staging Transurethral Resection on Recurrence and Progression Rates | completed | N/A | 109 | Saglik Bilimleri UniversitesiOTHER | 0 | Feb 26, 2021 | clinicaltrials |
| NCT02897765 | A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer | completed | Phase 1 | 34 | BioNTech US Inc.INDUSTRY | 1 | Feb 25, 2021 | clinicaltrials |
| NCT03125226 | TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer | completed | N/A | 12 | University of WashingtonOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT00006111 | Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract | completed | Phase 2 | 53 | UNICANCEROTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT04647981 | Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test.(Xpert Bladder) | completed | — | 320 | Clinique Beau SoleilOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT04726735 | Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer(IMMUN VESSIE) | completed | — | 100 | University Hospital, BordeauxOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT03977831 | Study Comparing Open Radical Cystectomy With Robot-assisted Cystectomy in Patients With Bladder Cancer | completed | N/A | 50 | Rigshospitalet, DenmarkOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT04723121 | Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers | completed | N/A | 204 | Mansoura UniversityOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT04184232 | Treatment of Recurrent Bladder Cancer With Dendritic Cells | completed | Phase 2 | 17 | Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusOTHER_GOV | 1 | Jan 22, 2021 | clinicaltrials |
| NCT02197897 | Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors(BCTamoxifen) | completed | Phase 2 | 15 | Baylor College of MedicineOTHER | 1 | Jan 13, 2021 | clinicaltrials |
| NCT04683536 | Bakircay University Cigli Training and Research Hospital(BUCEAH) | completed | — | 106 | Recep Tayyip Erdogan University Training and Research HospitalOTHER | 0 | Dec 24, 2020 | clinicaltrials |
| NCT02793128 | The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study(Olympus) | completed | Phase 3 | 71 | UroGen Pharma Ltd.INDUSTRY | 2 | Dec 22, 2020 | clinicaltrials |
| NCT02861196 | Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer | completed | N/A | 59 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT04661826 | ONCOFID-P-B in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder. | completed | Phase 2 | 60 | Fidia Farmaceutici s.p.a.INDUSTRY | 3 | Dec 10, 2020 | clinicaltrials |
| NCT04649970 | Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy | completed | — | 174 | Université de SousseOTHER | 0 | Dec 4, 2020 | clinicaltrials |
| NCT04635566 | Pharmacological Enhancement for Nocturnal Incontinence in Orthotopic Bladder Substitute | completed | N/A | 120 | Mansoura UniversityOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT02780687 | Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After Failure of Platinum Based Chemotherapy(LUX-Bladder 1) | completed | Phase 2 | 42 | Boehringer IngelheimINDUSTRY | 3 | Nov 18, 2020 | clinicaltrials |
| NCT02788201 | Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma | completed | Phase 2 | 8 | National Cancer Institute (NCI)NIH | 1 | Nov 6, 2020 | clinicaltrials |
| NCT01157676 | Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial | completed | N/A | 350 | University of MiamiOTHER | 1 | Nov 3, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Aug 13, 2021source: clinicaltrials